{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T12:34:07Z","timestamp":1764333247586,"version":"3.41.2"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Alzheimer\u2019s disease and other forms of dementia are disease that bring an increased global burden. However, the medicine developed to date remains limited. The purpose of this study is to predict drug repositioning candidates using a computational method that integrates gene expression profiles on Alzheimer\u2019s disease and compound-induced changes in gene expression levels.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Gene expression data on Alzheimer\u2019s disease were obtained from the Gene Expression Omnibus (GEO) and we conducted a meta-analysis of their gene expression levels. The reverse scores of compound-induced gene expressions were computed based on the reversal relationship between disease and drug gene expression profiles.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Reversal genes and the candidate compounds were identified by the leave-one-out cross-validation procedure. Additionally, the half-maximal inhibitory concentration (IC50) values and the blood-brain barrier (BBB) permeability of candidate compounds were obtained from ChEMBL and PubChem, respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>New therapeutic target genes and drug candidates against Alzheimer\u2019s disease were identified by means of drug repositioning.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnins.2022.989174","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T16:01:52Z","timestamp":1679068912000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Drug repurposing using meta-analysis of gene expression in Alzheimer\u2019s disease"],"prefix":"10.3389","volume":"16","author":[{"given":"Ha Young","family":"Jang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Mi","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In-Wha","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"13870","DOI":"10.1021\/acsomega.1c01526","article-title":"Therapeutic targeting of repurposed anticancer drugs in Alzheimer\u2019s disease: Using the multiomics approach.","volume":"6","author":"Advani","year":"2021","journal-title":"ACS Omega"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2020.104841","article-title":"Protective role of anticancer drugs in neurodegenerative disorders: A drug repurposing approach.","volume":"140","author":"Advani","year":"2020","journal-title":"Neurochem. Int."},{"key":"B3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1385\/1-59745-097-9:175","article-title":"Mining microarray data at NCBI\u2019s Gene expression omnibus (GEO)*.","volume":"338","author":"Barrett","year":"2006","journal-title":"Methods Mol. Biol."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.00242","article-title":"Clinically precedented protein kinases: Rationale for their use in neurodegenerative disease.","volume":"12","author":"Benn","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b158","article-title":"Alzheimer\u2019s disease.","volume":"338","author":"Burns","year":"2009","journal-title":"BMJ"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms16022","article-title":"Reversal of cancer gene expression correlates with drug efficacy and reveals therapeutic targets.","volume":"8","author":"Chen","year":"2017","journal-title":"Nat. Commun."},{"key":"B7","doi-asserted-by":"publisher","first-page":"742","DOI":"10.4103\/1673-5374.230303","article-title":"Use of curcumin in diagnosis, prevention, and treatment of Alzheimer\u2019s disease.","volume":"13","author":"Chen","year":"2018","journal-title":"Neural Regen. Res."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1186\/s40104-017-0164-6","article-title":"Efficient strategies for leave-one-out cross validation for genomic best linear unbiased prediction.","volume":"8","author":"Cheng","year":"2017","journal-title":"J. Anim. Sci. Biotechnol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"i84","DOI":"10.1093\/bioinformatics\/btg1010","article-title":"Combining multiple microarray studies and modeling interstudy variation.","volume":"19","author":"Choi","year":"2003","journal-title":"Bioinformatics"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/biom12020196","article-title":"DOTA: Deep learning optimal transport approach to advance drug repositioning for Alzheimer\u2019s disease.","volume":"12","author":"Chyr","year":"2022","journal-title":"Biomolecules"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-37247-6","article-title":"Metformin prevents cell tumorigenesis through autophagy-related cell death.","volume":"9","author":"De Santi","year":"2019","journal-title":"Sci. Rep."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease.","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"B13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/bib\/bbr013","article-title":"Exploiting drug-disease relationships for computational drug repositioning.","volume":"12","author":"Dudley","year":"2011","journal-title":"Brief Bioinform."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068324","article-title":"The microtubule regulatory protein stathmin is required to maintain the integrity of axonal microtubules in drosophila.","volume":"8","author":"Duncan","year":"2013","journal-title":"PLoS One"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1007\/s11064-022-03528-w","article-title":"Digoxin exhibits neuroprotective properties in a rat model of dementia.","volume":"47","author":"Erdogan","year":"2022","journal-title":"Neurochem. Res."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108171","article-title":"Enhancing autophagy in Alzheimer\u2019s disease through drug repositioning.","volume":"237","author":"Eshraghi","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12044","article-title":"Targeting dementias through cancer kinases inhibition.","volume":"6","author":"Fagiani","year":"2020","journal-title":"Alzheimers Dement"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-71767-4","article-title":"Enhancing microtubule stabilization rescues cognitive deficits and ameliorates pathological phenotype in an amyloidogenic Alzheimer\u2019s disease model.","volume":"10","author":"Fernandez-Valenzuela","year":"2020","journal-title":"Sci. Rep."},{"key":"B19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.nrl.2015.03.012","article-title":"Review of the advances in treatment for Alzheimer disease: Strategies for combating beta-amyloid protein.","volume":"33","author":"Folch","year":"2018","journal-title":"Neurologia"},{"key":"B20","doi-asserted-by":"publisher","first-page":"D945","DOI":"10.1093\/nar\/gkw1074","article-title":"The ChEMBL database in 2017.","volume":"45","author":"Gaulton","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: An analysis for the global burden of disease Study 2019.","volume":"7","year":"2022","journal-title":"Lancet Public Health"},{"key":"B22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.14283\/jpad.2021.62","article-title":"Senolytic therapy to modulate the progression of Alzheimer\u2019s disease (SToMP-AD): A pilot clinical trial.","volume":"9","author":"Gonzales","year":"2022","journal-title":"J. Prev. Alzheimers Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1158\/0008-5472.CAN-06-3633","article-title":"Identification of candidate molecular markers predicting sensitivity in solid tumors to dasatinib: Rationale for patient selection.","volume":"67","author":"Huang","year":"2007","journal-title":"Cancer Res."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-020-00450-7","article-title":"A review of computational drug repositioning: Strategies, approaches, opportunities, challenges, and directions.","volume":"12","author":"Jarada","year":"2020","journal-title":"J. Cheminform."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkr1071","article-title":"MetaQC: Objective quality control and inclusion\/exclusion criteria for genomic meta-analysis.","volume":"40","author":"Kang","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","article-title":"PubChem in 2021: New data content and improved web interfaces.","volume":"49","author":"Kim","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"D558","DOI":"10.1093\/nar\/gkx1063","article-title":"Data Portal for the Library of Integrated Network-based Cellular Signatures (LINCS) program: Integrated access to diverse large-scale cellular perturbation response data.","volume":"46","author":"Koleti","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.858126","article-title":"DeePred-BBB: A blood brain barrier permeability prediction model with improved accuracy.","volume":"16","author":"Kumar","year":"2022","journal-title":"Front. Neurosci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease.","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"},{"key":"B30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/biof.1396","article-title":"Resveratrol, pterostilbene, and dementia.","volume":"44","author":"Lange","year":"2018","journal-title":"Biofactors"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.drudis.2015.05.001","article-title":"Drug repositioning and repurposing: Terminology and definitions in literature.","volume":"20","author":"Langedijk","year":"2015","journal-title":"Drug Discov. Today"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002660","article-title":"Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial.","volume":"15","author":"Lawlor","year":"2018","journal-title":"PLoS Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/mp.2014.81","article-title":"HMGCR is a genetic modifier for risk, age of onset and MCI conversion to Alzheimer\u2019s disease in a three cohorts study.","volume":"20","author":"Leduc","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"B34","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.neubiorev.2020.09.011","article-title":"Function of WFS1 and WFS2 in the central nervous system: Implications for wolfram syndrome and Alzheimer\u2019s disease.","volume":"118","author":"Li","year":"2020","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21051666","article-title":"Contributions of DNA damage to Alzheimer\u2019s disease.","volume":"21","author":"Lin","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20071570","article-title":"Nifedipine modulates renal lipogenesis via the AMPK-SREBP transcriptional pathway.","volume":"20","author":"Lin","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer disease: An update on pathobiology and treatment strategies.","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/787805","article-title":"Calcium channel blockers, progression to dementia, and effects on amyloid beta peptide production.","volume":"2015","author":"Lovell","year":"2015","journal-title":"Oxid. Med. Cell Longev."},{"key":"B39","doi-asserted-by":"publisher","first-page":"5593","DOI":"10.3892\/ol.2018.8032","article-title":"Curcumin may serve an anticancer role in human osteosarcoma cell line U-2 OS by targeting ITPR1.","volume":"15","author":"Luo","year":"2018","journal-title":"Oncol. Lett."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n3127","article-title":"Aducanumab: European agency rejects Alzheimer\u2019s drug over efficacy and safety concerns.","volume":"375","author":"Mahase","year":"2021","journal-title":"BMJ"},{"key":"B41","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/d41586-021-01763-9","article-title":"Controversial Alzheimer\u2019s drug approval could affect other diseases.","volume":"595","author":"Mullard","year":"2021","journal-title":"Nature"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.3233\/JAD-181085","article-title":"A meta-analysis of Alzheimer\u2019s disease brain transcriptomic data.","volume":"68","author":"Patel","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-021-00843-2","article-title":"A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild Alzheimer\u2019s disease.","volume":"13","author":"Prins","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"B44","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jsbmb.2015.01.002","article-title":"Progesterone attenuates Abeta(25-35)-induced neuronal toxicity via JNK inactivation and progesterone receptor membrane component 1-dependent inhibition of mitochondrial apoptotic pathway.","volume":"154","author":"Qin","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s disease.","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"B46","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.jnutbio.2011.04.012","article-title":"Pharmacogenomic determination of genes associated with sensitivity or resistance of tumor cells to curcumin and curcumin derivatives.","volume":"23","author":"Sertel","year":"2012","journal-title":"J. Nutr. Biochem."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-30779-x","article-title":"Transcriptional network analysis of human astrocytic endfoot genes reveals region-specific associations with dementia status and tau pathology.","volume":"8","author":"Simon","year":"2018","journal-title":"Sci. Rep."},{"key":"B48","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/psyg.12085","article-title":"Clinical efficacy of lamotrigine and changes in the dosages of concomitantly used psychotropic drugs in Alzheimer\u2019s disease with behavioural and psychological symptoms of dementia: A preliminary open-label trial.","volume":"15","author":"Suzuki","year":"2015","journal-title":"Psychogeriatrics"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1093\/bioinformatics\/bts485","article-title":"An R package suite for microarray meta-analysis in quality control, differentially expressed gene analysis and pathway enrichment detection.","volume":"28","author":"Wang","year":"2012","journal-title":"Bioinformatics"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3233\/JAD-220262","article-title":"Making the Case for Accelerated Withdrawal of Aducanumab.","volume":"87","author":"Whitehouse","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101464","article-title":"Autophagy in Alzheimer\u2019s disease pathogenesis: Therapeutic potential and future perspectives.","volume":"72","author":"Zhang","year":"2021","journal-title":"Ageing Res. Rev."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2022.989174\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T16:01:54Z","timestamp":1679068914000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2022.989174\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,10]]},"references-count":51,"alternative-id":["10.3389\/fnins.2022.989174"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2022.989174","relation":{},"ISSN":["1662-453X"],"issn-type":[{"type":"electronic","value":"1662-453X"}],"subject":[],"published":{"date-parts":[[2022,11,10]]},"article-number":"989174"}}